Last reviewed · How we verify

NCT06363474

Cisternostomy Vs Decompressive Craniectomy for Severe Traumatic Brain Injury

Not yet recruiting NA Last updated 12 April 2024
What this trial tests

NA trial testing Decompressive Craniectomy in Severe Traumatic Brain Injury in 190 participants. Not yet recruiting.

Timeline
1 May 2024
Primary endpoint
1 May 2025
1 May 2025

Quick facts

Lead sponsorUniversity of Health Sciences Lahore
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment190
Start date1 May 2024
Primary completion1 May 2025
Estimated completion1 May 2025

Drugs / interventions tested

Conditions studied

Sponsor

University of Health Sciences Lahore

Who can join

Under 60, any sex, with Severe Traumatic Brain Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this clinical study is to compare the outcomes of two neurosurgical interventions, Cisternostomy and Decompressive Craniectomy (DC), for the management of severe Traumatic Brain Injury (TBI), assessed using the Glasgow Outcome Scale (GOS). Severe TBI presents challenges in managing intracranial pressure (ICP) and cerebral perfusion, often requiring surgical intervention. DC involves the removal of a section of the skull to reduce ICP, while Cisternostomy, a technique rooted in microsurgery, aims to alleviate brain edema and lower ICP by creating additional space for cerebrospinal fluid (CSF) circulation. This prospective study will be conducted at the Department of Neurosurgery, Punjab Institute of Neurosciences, Lahore. Patients meeting inclusion criteria will be randomized into Group A (DC) and Group B (Cisternostomy) following brain CT scans. Clinical evaluation will include regular follow-ups for 6 months post-surgery, recording data on GOS, duration of mechanical ventilation, ICU, and hospital stays. Analysis will be performed using SPSS 24, comparing outcomes between groups using Chi-square test and t-test. A significance level of p≤0.05 will be applied. It is hypothesized that Cisternostomy, as an adjunct to traditional TBI management, will effectively reduce ICP, resulting in improved GOS and reduced complications postoperatively, including decreased duration of mechanical ventilation and ICU stay, with sustained improvement observed at 6 months

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Decompressive Craniectomy

Trials testing the same drug.

Other recruiting trials for Severe Traumatic Brain Injury

Currently open trials in the same condition.

Other University of Health Sciences Lahore trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06363474.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing